Oncology Clinical Trials
From understanding the fundamentals of disease to developing the next generation of treatments, our team is on the path of innovation and bringing the world closer to a future where powerful healing overcomes any obstacle.
Primary performance sites:
- Sioux Falls, South Dakota
- Fargo, North Dakota
- Bismarck, North Dakota
- Bemidji, Minnesota
- Worthington, Minnesota
- Thief River Falls, Minnesota
The comprehensive program at Sanford Research:
- Employs 56 oncology investigators across our footprint
- Partners with the Dakota Cancer Collaborative on Translational Activity (DaCCoTA)
In 2020, we had over 4,500 oncology analytical cases and 1,426 total oncology enrollments. Of these trial enrollments, 210 were NCI funded, 628 were industry-sponsored and 588 were investigator-initiated.
An NCI-Sponsored Clinical Research Site
Our program is a National Cancer Institute Community Oncology Research Program (NCORP) Site. We’re supported by the NCI’s Division of Cancer Prevention and Sanford Health.
- Is one of 34 community programs
- Has over 80 clinical trials open for patient enrollment at any given time
- Offers the unique opportunity to conduct clinical research in community practice and to evaluate oncology care models through cancer care delivery research (CCDR) trials
Sanford Health has been a clinical research site sponsored by the NCI for 40 years.
Awards and Recognition
American Society of Clinical Oncology
QOPI Certification Program
Awarded to a program that creates a culture of excellence and self-examination that helps medical practices deliver the best care to patients.
NCI Community Oncology Research Program (NCORP)
Recognized for combined treatment and cancer control accrual between Aug. 1, 2014 and April 20, 2019.
Sanford NCORP of the Central Plains
Recognized with an award for overall accrual of cancer control and treatment trials.
NCI Children's Oncology Group
Certificate of Excellence
Recognized for the timely activation of CCDR studies and submission of data and for the quality of data submitted.
Minnesota Cancer Clinical Trials Network
Awarded $350,000 to expand access to cancer clinical trials across Minnesota.
Sanford NCORP of the North Central Plains
NRG Main Member Status
Achieved main member status based on patient accrual and satisfactory data quality, timeliness and audit performance.
National Cancer Institute
A new prospective cohort of 200,000 adults in the U.S. designed to further investigate the etiology of cancer and cancer outcomes, which may inform new approaches to precision prevention and early detection.
Wake Forest NCORP Research Base Annual Meeting
Third Place for Accrual to CCDR Trials
Recognized for efforts to launch CCDR.